{"task_id": "e11dffd7a986d06a", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 20/464)", "text": "H LINE\nfifth line plus home O2\n4\nCOPD Exacerbation\n\n--- Page 26 ---\nLONG TERM MANAGEMENT (CONT\u2019D)\nSEVENTH LINE\nlung volume reduction surgery\n(may be beneficial if upper lobe involvement and\npoor functional capacity) or lung transplant\nCanadian Thoracic Society Guidelines 2003\nTREATMENT ISSUES\nFACTORS FOR IMPENDING INTUBATION\ncardiac\nor respiratory failure, hemodynamic instability, mark\nedly elevated respiratory rate (>35/min), fatigue and\nlabored respiration, use of accessory muscles, wor\nsening hypercapnia, acidosis (especially lactic), stridor\n(impending\nupper\nairway\nobstruction),\nagonal\nbreathing (impending respiratory arrest)\nLIFE PROLONGING MEASURES FOR COPD\nsmok\ning cessation, supplemental O2\nINDICATIONS FOR SUPPLEMENTAL HOME O2\nABG done in room air. PaO2 <55 mmHg alone or\nPaO2 <60 mmHg in the presence of bilateral ankle\nedema, cor pulmonale, or hematocrit >56%\nSPECIFIC ENTITIES\na1 ANTITRYPSIN DEFICIENCY\n\u0002\nPATHOPHYSIOLOGY\nproduction of an abnormal\nprotease inhibitor (homozygous ZZ) with impaired\ntransport out of the liver. Serum level is only\n10 15% of normal ! increased protease activity\nleads to emphysema and cirrhosis (10%)\n\u0002\nDIAGNOSIS\na1 antitrypsin levels\n\u0002\nTREATMENTS\nsimilar\nto\nCOPD,\na1 antitrypsin\nreplacement\nBRONCHIOLITIS OBLITERANS\n\u0002\nPATHOPHYSIOLOGY\nsevere inflammation of bronch\nioles ! airflow obstruction. Very different from\nbronchiolitis\nobliterans\norganizing\npneumonia\n(BOOP)/cryptogenic organizing pneumonia (COP),\na parenchymal lung disorder\n\u0002\nCAUSES\ninfection (viral, mycoplasma), inflamma\ntory\n(ulcerative\ncolitis,\nrheumatoid\narthritis),\ntransplant (bone marrow, lung), toxic fumes,\nidiopathic\n\u0002\nTREATMENTS\nbronchiolitis\nobliterans\n(with\nan\norganizing intraluminal exudate and proliferative\ngranulation tissue polyp) is usually steroid respon\nsive. Constrictive bronchiolitis (late, fibrotic, con\ncentric) is not responsive to glucocorticoids\nBRONCHIECTASIS\n\u0002\nPATHOPHYSIOLOGY\nairway obstruction, destruc\ntion, altered immunity ! \" cellular and mediator\nSPECIFIC ENTITIES (CONT\u2019D)\ninflammatory response ! \" elastase, sputum pro\nduction ! recurrent infections ! vicious cycle !\npermanent dilatation of bronchi. Major types of\nbronchiectasis include\n\u0002\nCYLINDRICAL\nOR\nTUBULAR\nBRONCHIECTASIS\ndilated airways alone, sometimes represents\nresidual effect of pneumonia and may resolve\n\u0002\nVARICOSE\nBRONCHIECTASIS\nfocal\nconstrictive\nareas along the dilated airways\n\u0002\nSACCULAR\nOR\nCYSTIC\nBRONCHIECTASIS\nmost\nsevere form. Progressive dilatation of the air\nways, resulting in large cysts or saccules\n\u0002\nCAUSES\n\u0002\nFOCAL\nbroncholith,\npost infectious,\ntumor,\nextrinsic lymph node compression, post lobar\nresection, recurrent aspiration\n\u0002\nDIFFUSE\n\u0002\nPOST-INFECTIONS\nbacterial\n(Pseudomonas,\nHaemophilus), mycobacterium, fungal, viral\n(adenovirus, measles, influenza, HIV)\n\u0002\nIMMUNODEFICIENCY\ncancer, chemotherapy,\nhypogammaglobulinemia,\nimmunosup\npression, sequelae of toxic inhalation or\naspiration of foreign body\n\u0002\nINTERSTITIAL\nLUNG\nDISEASE\ntraction\nbronchiectasis\n\u0002\nINFLAMMATORY\nRA,\nSLE,\nSjogren\u2019s\nsyn\ndrome, relapsing polychondritis, IBD\n\u0002\nINHERITED\na1 antitrypsin deficiency, cystic\nfibrosis, primary ciliary dyskinesia (Kartage\nner\u2019s syndrome, Young\u2019s syndrome), tracheo\nbronchomegaly (Mounier Kuhn syndrome),\ncartilage deficiency (Williams Campbell syn\ndrome), Marfan\u2019s syndrome\n\u0002\nDIAGNOSIS\nhigh resolution CT chest (signet ring\nsign), PFT (obstruction \u0007 reversibility)\n\u0002\nTREATMENTS\nexercises, chest physiotherapy, and\nbronchodilators similar to COPD; however, if rever\nsible, inhaled corticosteroids should be given early.\nEnsure adequate systemic hydration. Effective\ntreatment of exacerbations\nNEJM 2002 346:18\nRelated Topics\nCryptogenic Organizing Pneumonia (p. 15)\nPulmonary Function Tests (p. 21)\nSmoking (p. 418)\nCOPD Exacerbation\n5", "text_length": 3767, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 20/464)", "type": "chunk", "chunk_index": 19, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.259200", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.259976", "status": "complete", "chunks_added": 2}